CDC releases less restrictive guidelines for opioid prescribing. The Centers for Disease Control and Prevention (CDC) has released new guidelines for prescribing opioids for pain that address concerns about misinterpretation of the previous 2016 guidelines. Those earlier guidelines, which were intended to stem harm from opioid addiction, stated that prescribers should not increase an opioid dose above 90 morphine milligram equivalents and should prescribe opioids for three days' duration or less for most patients. Prescribers, as well as health insurers and pharmacies, interpreted the recommendations as rigid limits and either rapidly tapered or abruptly cut off patients on higher doses. The new guidelines do away with specific dose or duration recommendations and make clear that "recommendations are voluntary and are intended to support, not supplant, individualized, person-centered care" while still providing guidance to reduce opioid therapy risks. For the new guidelines, go to http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639433/pdf/rr7103a1.pdf.